Cargando…
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis
Patients with interstitial lung disease can develop a progressive fibrosing phenotype characterised by an irreversible, progressive decline in lung function despite treatment. Current therapies slow, but do not reverse or stop, disease progression and are associated with side-effects that can cause...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949383/ https://www.ncbi.nlm.nih.gov/pubmed/36813290 http://dx.doi.org/10.1183/16000617.0206-2022 |